Asian Phytoceuticals PCL (BKK:APCO)
Thailand · Delayed Price · Currency is THB 2.620
-0.020 (-0.76%)
Jun 12, 2026, 4:36 PM ICT
Asian Phytoceuticals PCL Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 201.88 | 200.17 | 210.83 | 292.76 | 250.38 | 223.35 | |
Revenue Growth (YoY) | -1.05% | -5.06% | -27.99% | 16.93% | 12.10% | -9.84% |
Cost of Revenue | 31.48 | 31.15 | 40.96 | 57.25 | 47.94 | 46.26 |
Gross Profit | 170.4 | 169.02 | 169.87 | 235.52 | 202.44 | 177.09 |
Selling, General & Admin | 113.16 | 115.44 | 120.1 | 119.72 | 116.49 | 106.29 |
Other Operating Expenses | -2.4 | -2.38 | -3.34 | -1.09 | -2.08 | -3.03 |
Operating Expenses | 110.77 | 113.06 | 116.76 | 118.63 | 114.41 | 103.27 |
Operating Income | 59.64 | 55.96 | 53.11 | 116.89 | 88.03 | 73.82 |
Interest Expense | -1.4 | -1.61 | -1.59 | -0.66 | -0.57 | -0.86 |
Interest & Investment Income | 6.12 | 6.88 | 13.05 | 15.22 | 12.41 | 10.31 |
Earnings From Equity Investments | 1.35 | 1.65 | 1.67 | 1.26 | 0.61 | -0.28 |
EBT Excluding Unusual Items | 65.71 | 62.88 | 66.24 | 132.72 | 100.48 | 82.98 |
Gain (Loss) on Sale of Investments | 2.31 | 6.87 | 1.73 | 0.47 | -0.01 | 2.51 |
Gain (Loss) on Sale of Assets | 8.33 | - | - | - | - | - |
Pretax Income | 76.34 | 69.75 | 67.98 | 133.18 | 100.47 | 85.49 |
Income Tax Expense | 14.41 | 13.14 | 12.21 | 24.45 | 19.28 | 16.79 |
Earnings From Continuing Operations | 61.93 | 56.6 | 55.77 | 108.74 | 81.2 | 68.7 |
Minority Interest in Earnings | -1.47 | -1.19 | -1.06 | -1.24 | -0.28 | - |
Net Income | 60.46 | 55.41 | 54.71 | 107.49 | 80.92 | 68.7 |
Net Income to Common | 60.46 | 55.41 | 54.71 | 107.49 | 80.92 | 68.7 |
Net Income Growth | 19.10% | 1.28% | -49.10% | 32.84% | 17.78% | -1.82% |
Shares Outstanding (Basic) | 606 | 616 | 608 | 601 | 600 | 600 |
Shares Outstanding (Diluted) | 606 | 616 | 608 | 601 | 600 | 600 |
Shares Change (YoY) | -3.43% | 1.28% | 1.23% | 0.11% | -0.03% | -0.02% |
EPS (Basic) | 0.10 | 0.09 | 0.09 | 0.18 | 0.13 | 0.11 |
EPS (Diluted) | 0.10 | 0.09 | 0.09 | 0.18 | 0.13 | 0.11 |
EPS Growth | 23.33% | - | -49.72% | 32.69% | 17.82% | -1.80% |
Free Cash Flow | 54.51 | 51.42 | 35.36 | 120.72 | 99.86 | 83.22 |
Free Cash Flow Per Share | 0.09 | 0.08 | 0.06 | 0.20 | 0.17 | 0.14 |
Dividend Per Share | 0.091 | 0.091 | 0.092 | 0.180 | 0.155 | 0.123 |
Dividend Growth | -1.09% | -1.09% | -48.89% | 16.13% | 25.61% | 2.83% |
Gross Margin | 84.41% | 84.44% | 80.57% | 80.45% | 80.85% | 79.29% |
Operating Margin | 29.54% | 27.96% | 25.19% | 39.93% | 35.16% | 33.05% |
Profit Margin | 29.95% | 27.68% | 25.95% | 36.72% | 32.32% | 30.76% |
Free Cash Flow Margin | 27.00% | 25.69% | 16.77% | 41.24% | 39.88% | 37.26% |
EBITDA | 64.65 | 61.12 | 59.29 | 123.69 | 94.84 | 81.48 |
EBITDA Margin | 32.02% | 30.54% | 28.12% | 42.25% | 37.88% | 36.48% |
D&A For EBITDA | 5.01 | 5.16 | 6.18 | 6.8 | 6.81 | 7.66 |
EBIT | 59.64 | 55.96 | 53.11 | 116.89 | 88.03 | 73.82 |
EBIT Margin | 29.54% | 27.96% | 25.19% | 39.93% | 35.16% | 33.05% |
Effective Tax Rate | 18.88% | 18.84% | 17.96% | 18.36% | 19.19% | 19.64% |